Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
National Beverage
FIZZ
$2.89B
| $127M | 0.11% |
5,735,000
+394,000
| +7% | +$8.5M |
|
202
Southwest Airlines
LUV
$22.3B
| $127M | 0.11% |
2,343,380
+1,731,600
| +283% | +$90.6M |
|
|
VGR
203
DELISTED
Vector Group Ltd.
VGR
| $126M | 0.11% |
14,897,266
+1,452,145
| +11% | +$11.1M |
|
204
NVR
NVR
$17.1B
| $125M | 0.11% |
33,760
+1,400
| +4% | +$4.93M |
|
|
CEO
205
DELISTED
CNOOC Limited
CEO
| $125M | 0.11% |
822,742
+111,142
| +16% | +$17.5M |
|
206
JPMorgan Chase
JPM
$962B
| $125M | 0.11% |
1,064,191
-1,901,595
| -64% | -$215M |
|
207
Copa Holdings
CPA
$5.49B
| $125M | 0.11% |
1,261,086
+231,186
| +22% | +$23.3M |
|
208
Enbridge
ENB
$113B
| $124M | 0.11% |
3,545,424
-238,577
| -6% | -$8.25M |
|
209
Pan American Silver
PAAS
$21.8B
| $124M | 0.11% |
7,920,214
-884,999
| -10% | -$14.3M |
|
210
Brady Corp
BRC
$4.48B
| $124M | 0.11% |
2,339,598
+198,500
| +9% | +$10M |
|
211
Elevance Health
ELV
$84.7B
| $123M | 0.1% |
+514,073
| New | +$141M |
|
212
Simon Property Group
SPG
$71B
| $123M | 0.1% |
791,605
+121,300
| +18% | +$18.9M |
|
213
lululemon athletica
LULU
$14.3B
| $123M | 0.1% |
639,400
+9,900
| +2% | +$1.85M |
|
214
Automatic Data Processing
ADP
$108B
| $123M | 0.1% |
760,900
+602,401
| +380% | +$99.5M |
|
|
SNP
215
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $123M | 0.1% |
2,088,603
+199,003
| +11% | +$12.3M |
|
216
Acuity Brands
AYI
$10.7B
| $123M | 0.1% |
909,000
+284,400
| +46% | +$37M |
|
217
Ligand Pharmaceuticals
LGND
$5.76B
| $121M | 0.1% |
1,954,721
-98,414
| -5% | -$6.18M |
|
218
Wingstop
WING
$3.03B
| $121M | 0.1% |
1,390,700
+211,600
| +18% | +$20.1M |
|
219
Dollar Tree
DLTR
$24.6B
| $121M | 0.1% |
1,060,698
-393,597
| -27% | -$41.2M |
|
220
Rayonier
RYN
$6.45B
| $121M | 0.1% |
4,729,604
+303,719
| +7% | +$7.78M |
|
221
Regency Centers
REG
$13.9B
| $121M | 0.1% |
1,739,690
-275,069
| -14% | -$18.3M |
|
222
Best Buy
BBY
$17.6B
| $121M | 0.1% |
1,751,630
-965,900
| -36% | -$67.4M |
|
|
AMTD
223
DELISTED
TD Ameritrade Holding Corp
AMTD
| $120M | 0.1% |
2,575,026
+950,700
| +59% | +$45.5M |
|
224
Ecopetrol
EC
$35B
| $120M | 0.1% |
7,042,606
+332,906
| +5% | +$5.77M |
|
|
CSGS
225
DELISTED
CSG Systems International
CSGS
| $120M | 0.1% |
2,319,324
-3,346
| -0.1% | -$171K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.